NCT04928261 2026-01-22Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic TherapyOttawa Hospital Research InstitutePhase 4 Active not recruiting52 enrolled
NCT02696707 2025-12-18OTT 15-05Ottawa Hospital Research InstitutePhase 4 Completed200 enrolled 8 charts
NCT07254221 2025-12-10ROSUBREASTShiraz University of Medical SciencesPhase 4 Not yet recruiting400 enrolled